Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 1, 1999, Pages 35-40

  Woodnutt, Gary ^a   Berry, Valerie ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CLAVULANIC ACID; PENICILLIN G; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFECTION; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032946640     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.1.35     Document Type: Article

References (16)

1. Andes, D., A. Urban, and W. A. Craig. 1995. In-vivo activity of amoxicillin and amoxicillin/clavulanate against penicillin-resistant pneumococci, abstr. p. A82, 16. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Applebaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
3. Barry B., M. Muffat-Joly, P. Gehanno, and J. Pocidalo. 1993. Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 37:1599-1603.
4. Block, S. L., C. J. Harrison, J. A. Hedrick, R. D. Tyler, R. A. Smith, E. Keegan, and S. A. Chartrand. 1995. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr. Infect. Dis. 15:751-759.
5. Caputo, G. M., P. C. Applebaum, and H. H. Liu. 1993. Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features. Arch. Intern. Med. 153:1301-1310.
6. Drusano, G. L. 1988. Role of pharmacokinetics in outcome of infections. Antimicrob. Agents Chemother. 32:289-297.
7. Drusano, G. L., and F. W. Goldstein. 1996. Relevance of the Alexander Project: pharmacodynamic considerations. J. Antimicrob. Chemother. 38(Suppl. A):141-154.
8. Felmingham, D., and R. N. Gruneberg. 1996. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project. J. Antimicrob. Chemother. 38(Suppl. A):1-57.
9. Friedland, I. R., and G. H. McCracken. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
10. Gold, H. S., and R. C. Moellering. 1996. Antimicrobial-drug resistance. N. Engl. J. Med. 335:1445-1453.
11. Jackson, D., D. L. Cooper, R. Horton, P. F. Langley, D. S. Staniforth, and A. J. Sutton. 1982. Absorption, pharmacokinetic and metabolic studies with Augmentin. In E. A. P. Croydon and M. F. Michael (ed.). Augmentin: clavulanate potentiated amoxycillin. Proceedings of the European Symposium. Scheveningen, The Netherlands. Excerpta Medica, Amsterdam, The Netherlands.
12. Lister, P. D., A. Pong, S. A. Chartrand, and C. C. Sanders. 1997. Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies. Antimicrob. Agents Chemother. 41:1926-1932.
13. Nelson, J. D., H. Kusmiesz, and S. Shelton. 1982. Pharmacokinetics of potassium clavulanate in combination with amoxicillin in pediatric patients. Antimicrob. Agents Chemother. 21:681-682.
14. Smith, G. M., and K. H. Abbott. 1994. Development of experimental respiratory infections in neutropenic rats with either penicillin-resistant Streptococcus pneumoniae or β-lactamase-producing Haemophilus influenzae. Antimicrob. Agents Chemother. 38:608-610.
15. Vogelman, B., S. Gundmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158:831-847.
16. Woodnutt, G., V. Berry, and J. Bryant. 1996. Evaluation of reduced dosing schedule of amoxicillin (AMX) using two pharmacodynamic models, abstr. A40, p. 8. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.